Search Results - "Toldi, Jozsef"

Refine Results
  1. 1

    Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects by Lukacs, Melinda, Tajti, Janos, Fulop, Ferenc, Toldi, Jozsef, Edvinsson, Lars, Vecsei, Laszlo

    Published in Current medicinal chemistry (01-01-2017)
    “…Migraine is a primary headache disorder. Despite numerous studies conducted with the aim to understand the pathophysiology of migraine, several aspects are…”
    Get more information
    Journal Article
  2. 2

    The Therapeutic Impact of New Migraine Discoveries by Vécsei, László, Lukács, Melinda, Tajti, János, Fülöp, Ferenc, Toldi, József, Edvinsson, Lars

    Published in Current medicinal chemistry (01-01-2019)
    “…Migraine is one of the most disabling neurological conditions and associated with high socio-economic costs. Though certain aspects of the pathomechanism of…”
    Get more information
    Journal Article
  3. 3

    The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection by Vamos, Eniko, Pardutz, Arpad, Klivenyi, Peter, Toldi, Jozsef, Vecsei, Laszlo

    Published in Journal of the neurological sciences (15-08-2009)
    “…Abstract The metabolism of tryptophan mostly proceeds through the kynurenine pathway. The biochemical reaction includes both an agonist (quinolinic acid) at…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines by Tanaka, Masaru, Toldi, József, Vécsei, László

    “…Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases (NDs), presenting a broad range of symptoms from motor…”
    Get full text
    Journal Article
  5. 5

    Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction by Szalardy, Levente, Zadori, Denes, Toldi, Jozsef, Fulop, Ferenc, Klivenyi, Peter, Vecsei, Laszlo

    Published in Current topics in medicinal chemistry (01-08-2012)
    “…A number of neurodegenerative diseases have been associated with potentially neurotoxic alterations in the kynurenine pathway. Due to the potent inhibitory…”
    Get more information
    Journal Article
  6. 6

    Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System by Majláth, Zsófia, Toldi, József, Fülöp, Ferenc, Vécsei, László

    Published in Current medicinal chemistry (01-01-2016)
    “…Parkinson's disease is a common progressive neurodegenerative disorder presenting with characteristic motor symptoms. Non-motor dysfunctions and therapyrelated…”
    Get more information
    Journal Article
  7. 7

    Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design by Tajti, Janos, Majlath, Zsofia, Szok, Delia, Csati, Anett, Toldi, Jozsef, Fulop, Ferenc, Vecsei, Laszlo

    Published in Current pharmaceutical design (01-01-2015)
    “…Though migraine and neurodegenerative disorders have a high socioeconomic impact, their therapeutic management has not been fully addressed. Their…”
    Get more information
    Journal Article
  8. 8

    Kynurenines and drug research by Tóth, Fanni, Fülöp, Ferenc, Szatmári, István, Toldi, József, Dékány, Imre, Vécsei, László

    Published in Orvosi hetilap (01-03-2020)
    “…Currently kynurenines are considered a hot topic, because of their involvement in numerous physiological and pathological processes. The essential amino acid,…”
    Get more information
    Journal Article
  9. 9

    Effect of probenecid on the pain-related behaviour and morphological markers in orofacial formalin test of the rat by Fejes-Szabó, Annamária, Bohár, Zsuzsanna, Nagy-Grócz, Gábor, Vámos, Enikő, Tar, Lilla, Pődör, Borbála, Tajti, János, Toldi, József, Vécsei, László, Párdutz, Árpád

    Published in CNS & neurological disorders drug targets (01-01-2015)
    “…Probenecid has been widely used in the treatment of gout, but evidence suggests that it may also have antinociceptive effects in different inflammatory and…”
    Get more information
    Journal Article
  10. 10

    Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion by Marosi, Máté, Fuzik, János, Nagy, Dávid, Rákos, Gabriella, Kis, Zsolt, Vécsei, László, Toldi, József, Ruban-Matuzani, Angela, Teichberg, Vivian I., Farkas, Tamás

    Published in European journal of pharmacology (14-02-2009)
    “…Various acute brain pathological conditions are characterized by the presence of elevated glutamate concentrations in the brain interstitial fluids. It has…”
    Get full text
    Journal Article
  11. 11

    Kynurenines in the CNS: recent advances and new questions by Vécsei, László, Szalárdy, Levente, Fülöp, Ferenc, Toldi, József

    Published in Nature reviews. Drug discovery (01-01-2013)
    “…Key Points Kynurenic acid has potentially neuroprotective actions, such as antagonism at NMDA ( N -methyl- D -aspartate) receptors, inhibition of glutamate…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders by Sas, Katalin, Robotka, Hermina, Toldi, József, Vécsei, László

    Published in Journal of the neurological sciences (15-06-2007)
    “…Abstract The mitochondria have several important functions in the cell. A mitochondrial dysfunction causes an abatement in ATP production, oxidative damage and…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Changing the face of kynurenines and neurotoxicity: therapeutic considerations by Bohár, Zsuzsanna, Toldi, József, Fülöp, Ferenc, Vécsei, László

    “…Kynurenines are the products of tryptophan metabolism. Among them, kynurenine and kynurenic acid are generally thought to have neuroprotective properties,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Species-specific neuronal localization of kynurenine aminotransferase-2 in the mouse cerebellum by Balog, Emma, Jenei, Gyula, Gellért, Levente, Ono, Etsuro, Vécsei, László, Toldi, József, Kis, Zsolt

    Published in Neurochemistry international (01-01-2021)
    “…The immunohistochemical pattern of kynurenine aminotransferase-2 (KAT-2) - the key role enzyme in the production of neuroactive and neuroprotective kynurenic…”
    Get full text
    Journal Article
  17. 17

    Altered tryptophan metabolism in Parkinson's disease: A possible novel therapeutic approach by Szabó, Nikoletta, Kincses, Zsigmond Tamás, Toldi, József, Vécsei, Laszló

    Published in Journal of the neurological sciences (15-11-2011)
    “…Abstract Parkinson's disease (PD) is one of the most common disabling neurodegenerative diseases. Although several therapeutic approaches are available, there…”
    Get full text
    Journal Article
  18. 18

    Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs by Fehér, Evelin, Szatmári, István, Dudás, Tamás, Zalatnai, Anna, Farkas, Tamás, Lőrinczi, Bálint, Fülöp, Ferenc, Vécsei, László, Toldi, József

    Published in Molecules (Basel, Switzerland) (26-09-2019)
    “…Kynurenic acid (KYNA), a metabolite of tryptophan, as an excitatory amino acid receptor antagonist is an effective neuroprotective agent in case of…”
    Get full text
    Journal Article
  19. 19

    Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets by Zádori, Dénes, Veres, Gábor, Szalárdy, Levente, Klivényi, Péter, Toldi, József, Vécsei, László

    Published in Journal of Alzheimer's disease (01-01-2014)
    “…The impairment of glutamatergic neurotransmission plays an important role in the development of Alzheimer's disease (AD). The pathological process, which…”
    Get more information
    Journal Article
  20. 20

    Memantine and Kynurenic Acid: Current Neuropharmacological Aspects by Majlath, Zsofia, Torok, Nora, Toldi, Jozsef, Vecsei, Laszlo

    Published in Current neuropharmacology (01-02-2016)
    “…Glutamatergic neurotransmission, of special importance in the human brain, is implicated in key brain functions such as synaptic plasticity and memory. The…”
    Get full text
    Journal Article